PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Piramal Pharma invests $32M to expand US facility for API production

Growing customer demand in the API space is driving the investment Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufactu...
Continue Reading →
News

World first as UK launches COVID-19 vaccination programme

The UK has embarked on a large-scale vaccination programme to protect the population against COVID-19, with Margaret Keenan becoming the first in the world to receiv...
Continue Reading →
News

Lilly announces 650,000 additional doses of neutralizing antibody bamlanivimab (LY-CoV555) purchased by U.S. government to treat COVID-19

The U.S. government has purchased 650,000 additional doses of Eli Lilly and Company's (NYSE: LLY) neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. The purchase...
Continue Reading →
News

AZD1222 Oxford Phase III trials interim analysis results published in The Lancet

Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222, peer-reviewed and published in The Lancet today, demonstrated ...
Continue Reading →
News

Indivior faces lawsuit from ex-parent company RB over Suboxone marketing scheme

Indivior has taken hit after hit from U.S. prosecutors for its marketing of Suboxone Film, a notorious addiction therapy treatment. With one executive in jail and bi...
Continue Reading →
News

UK secures another two million doses of Moderna’s COVID-19 vaccine

The UK government has secured an additional two million doses of Moderna’s COVID-19 vaccine mRNA-1273, taking the agreed supply up to seven million doses in total. ...
Continue Reading →
News

Researchers warn pandemic could delay cancer advances ‘by almost a year’

A new survey has detailed cancer researchers’ concerns that advances for patients could be delayed by nearly 18 months due to the impact of the COVID-19 pandemic. ...
Continue Reading →
News

Eisai enters collaboration agreement with Wren Therapeutics

Japanese pharma company Eisai has entered into a research collaboration agreement with Cambridge, UK-based Wren Therapeutics to discover new small molecules for the ...
Continue Reading →
News

COVID-19 could cause long-term lung damage, research finds

Research conducted at Oxford University suggests that COVID-19 may be causing lung-damage in patients that can be detected over three months after the initial infect...
Continue Reading →
News

AZ sells rights to statin med Crestor to Grünenthal

AstraZeneca (AZ) has announced that it will sell the rights to statin medication Crestor to Grünenthal in over 30 European countries. Crestor (rosuvastatin) is ind...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026